WE-REACH

WE-REACH LOGO

The Center for Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH) provides teaching and funding tools to accelerate the development of therapeutic, device, and diagnostic products to address significant challenges in health.

With support from the NIH and in partnership with ITHS, CoMotion, IPD, the UW Office of Research, and the School of Pharmacy, WE-REACH provides an array of service designed to bridge early stage products into health impact. These services include:

  1. Training through a Biomedical Innovation Bootcamp (Winter, Summer);
  2. An annual symposium held in partnership with ITHS;
  3. 4-6 yearly WE-REACH Awards of up to $200,000 in direct costs for activity- and time-based, stage-gated, and milestone-driven projects. All awardees will be assigned a WE-REACH project manager and given access to a team of experts for product development, regulatory strategy, intellectual property, market analysis, and follow-on grant development.

WE-REACH is governed by 3 main committees:

  1. The Executive Leadership Group (ELG)—Manages the day-to-day operations of WE-REACH;
  2. The Executive Committee (ExeC)—Reviews and manages WE-REACH affairs within the University of Washington ecosystem;
  3. The Program Steering Committee (PSC)—Provides input and coordination between WE-REACH and external industry leaders in the Pacific Northwest.

Our Partners

Partners are founding members or organizations providing funding and support for WE-REACH projects and initiatives.

National Institutes of Health Logo
UW Logo
Institute of Translational Health Sciences Logo
CoMotion Logo
Institute for Protein Design Logo
UW School of Pharmacy Logo

Collaborators

Collaborators provide value-add services, educational resources, technical support, project pipelines, and other opportunities to ensure the success of WE-REACH initiatives.

University of Washington School of Law logo

 

Foster school of business logo

 

Seattle Children's Logo

 

Ascend Hub logo

WE-REACH is supported in part by NIH Grant #1 U01 HL152401-01 in addition to the partners listed above.